HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children

Signup
Browse Studies

City:   Little Rock
State:   Arkansas
Zip Code:   72202
Conditions:   Asthma - Quality of Life - Children - Health Disparities - Telemedicine Education
Purpose:   The overall goal of this proposal is to examine the efficacy of a school-based asthma telemedicine intervention in a predominately minority, low-income rural pediatric population.
Study Summary:   A total of 1110 subjects will be enrolled in this research study. Five hundred forty (540) subjects will be between the ages of 7-14 years. The remaining 540 subjects will be comprised of the primary caregiver of the participants. Thirty (30) school nurse/s providing care to the 270 intervention participants will also be enrolled in the study. To test our hypotheses, the investigators will conduct a cluster randomized trial with 540 children, ages 7-14 years and their parent/guardian(s), to address the following specific aims: Specific Aim 1: Examine the efficacy of a school-based asthma telemedicine intervention in improving asthma-related health outcomes in an intervention group compared to children receiving usual care. Specific Aim 2: Determine the effects of a school-based asthma telemedicine intervention on asthma self-management skills of intervention caregivers and participants compared to a usual care group. The investigators will compare changes in asthma self-efficacy, quality of life, and knowledge between groups. Specific Aim 3: Determine the cost of the intervention in relation to health outcomes.
Criteria:   Inclusion Criteria: The investigators will recruit students (ages 7-14 years) with asthma who are currently enrolled in public school districts located in the Delta region of Arkansas. Eligibility of identified children will be determined by a brief telephone survey. The survey questions will determine if the child fulfills inclusion/exclusion criteria. 1. Age ≥ 7 and ≤ 14 years. 2. Use of asthma medications for acute relief of symptoms (rescue) or for control of symptoms (preventive) in the past 6 months. Children not on a controller who report using a rescue medication only for prevention of exercised-induced symptoms will not be eligible for the study. 3. Physician-diagnosed asthma by parent/caregiver report. OR 4. In the absence of a formal physician diagnosis, the caregiver must report symptoms consistent with at least mild persistent asthma. The investigators will use asthma screening criteria to ensure that participants meet eligibility requirements. Participants must establish a history of episodic airflow obstruction or airway hyperresponsiveness and meet NHLBI guidelines for persistent asthma. Mild persistent asthma will be defined as any 1 of the following during the prior 4 weeks (by caregiver report): - An average of > 2 days per week with asthma symptoms - > 2 days per week with rescue medication use - > 2 nights per month awakened with nighttime symptoms - Minor limitation of activity - ≥ 2 episodes of asthma during the past year that have required systemic corticosteroids Exclusion Criteria: 1. Significant underlying respiratory disease other than asthma (such as cystic fibrosis or chronic lung disease) that could potentially interfere with asthma-related outcome measures. 2. Significant co-morbid conditions (such as severe developmental delay) that could preclude participation in an education-based intervention. 3. Inability to speak or understand English (child or parent). 4. Children in foster care or other situations in which consent cannot be obtained from a guardian. 5. Prior enrollment in the study. 6. Families without access to a working telephone as all survey data will be collected via telephone.
NCT ID:   NCT01167855
Primary Contact:   Principal Investigator
Tamara T. Perry, M.D.
University of Arkansas

Rita C Hudson Brown, BA
Phone: 501-364-1538 ext. 41538
Email: brownritac@uams.edu
Backup Contact:   Email: broberts@uams.edu
Brandi L Roberts, MPH
Phone: 501-364-3641 ext. 43641
Location Contact:   Little Rock, Arkansas 72202
United States

Brandi L Roberts, BS
Phone: 501-364-3641
Email: broberts@uams.edu

Site Status: Recruiting

Click here to see:
  • Clinical trials for Asthma in Little Rock, Arkansas

Data Source:   ClinicalTrials.gov
Date Processed:   June 18, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Restless Legs Syndrome (RLS) - Little Rock AR

Postherpetic Neuralgia (Post-shingles pain) - Little Rock AR

Multiple Myeloma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma - Little Rock AR

Low Back Pain and Constipation - Sherwood AR

Pediatric Depression - Little Rock AR

Osteoartritis of the Hands - Little Rock AR

Within 50 Miles

Within 100 Miles

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.